Soundhound AI, Inc. SOUN
620 filings, 4 in the last 30 days
SEC filing indexWhat the 8-Ks said
4 events in the last 3 years: the officer, auditor, restatement, cyber, restructuring, listing, impairment and debt items. One line each, the filing's own words.
- Nov 13, 2026 CEO, CFO, COO or CAOCAO change “Appointment of Chief Accounting Officer” 8-K item 5.02 · all documents
- Nov 5, 2026 RestructuringReported exit or disposal costs from a restructuring “Costs Associated with Exit or Disposal Activities. On November 4, 2026, the Company implemented a restructuring plan (the “Plan”) intended to align our teams and resources with our strategic priorities to drive long-term profitability. The Plan includes a reduction of the Company’s current global workforce by approximately 27%. Decisions regarding the elimination of positions are subject to local…” 8-K item 2.05 · all documents
- Sep 4, 2026 CEO, CFO, COO or CAOCFO change “Effective upon the consummation of the Mergers, the Board of Directors of the Company appointed John Collins as Chief Financial Officer of the Company.” 8-K item 5.02 · all documents
- Mar 18, 2026 CEO, CFO, COO or CAOCFO change “(the “Company”) announced that Nitesh Sharan will resign as Chief Financial Officer, effective April 3, 2026 (the “Transition Date”), to assume a leadership role at a company in the quantum computing space.” 8-K item 5.02 · all documents
From the SEC filing index and the text of each 8-K. A line appears only when the 8-K names one of these items; for item 5.02 only a move of the CEO, CFO, COO or chief accounting officer. Older 8-Ks may have no text downloaded, so they show no quote.
Late filings, 8-K notices and going concern
Facts worth reading in the filing: 1 found
-
Late filing notices (NT 10-K, NT 10-Q)NT 10-K filed Mar 4, 2025: the company told the SEC its 10-K for the period to Dec 31, 2024 would be late (Form 12b-25).
-
8-K notices: listing, impairment, debt triggerNo item 3.01, 2.06 or 2.04 in the last 2 years.
-
Going-concern language in the 10-KNo statement of substantial doubt in the latest 10-K.
Facts to read in the filing, not a verdict: many companies with one of these carry on normally, and a company with neither can still have problems.
Every filing on one line
Each mark is a filing or an event in one; the bigger square is a 10-K. Hover for what it is, click to open it.
All 88 events
- Nov 13, 2026 Officer CAO changeAppointment of Chief Accounting Officer
- Nov 13, 2026 8-K Acquisition or sale of assets completed (amended)8-K item 2.01
- Nov 9, 2026 Planned sale •Diana Sroka (Director) adopted a 10b5-1 trading planreported in the 10-Q, up to 7,553 shares, runs to Jun 30, 2027
- Nov 9, 2026 Planned sale •James M. Hom (Chief Product Officer and Director) adopted a 10b5-1 trading planreported in the 10-Q, up to 377,527 shares, runs to Mar 31, 2027
- Nov 9, 2026 Planned sale •Dr. Keyvan Mohajer (Chief Executive Officer and Director) adopted a 10b5-1 trading planreported in the 10-Q, up to 1,171,059 shares, runs to Feb 28, 2027
- Nov 9, 2026 Planned sale •Majid Emami (Chief Science Officer and Senior Vice President) adopted a 10b5-1 trading planreported in the 10-Q, up to 439,253 shares, runs to Jun 30, 2027
- Nov 9, 2026 Planned sale •Michael Zagorsek (Chief Operating Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 1,188,139 shares, runs to Mar 31, 2027
- Nov 9, 2026 10-Q Quarterly report (10-Q)period ended Sep 30, 2026
- Nov 5, 2026 8-K Quarterly results, Restructuring or exit costs8-K items 2.02, 2.05
- Sep 17, 2026 Planned sale DIANA SROKA (Director) gave notice of a planned sale of 1,552 shares worth about $9KForm 144, approximate sale date Sep 17, 2026, under a 10b5-1 plan adopted May 28, 2026
- Sep 15, 2026 Planned sale ZAGORSEK MICHAEL (Officer) gave notice of a planned sale of 71,113 shares worth about $460KForm 144, approximate sale date Sep 15, 2026
- Sep 15, 2026 Planned sale EMAMI MAJID (Officer) gave notice of a planned sale of 38,730 shares worth about $251KForm 144, approximate sale date Sep 15, 2026
- Sep 15, 2026 Planned sale HOM JAMES MING (Officer, Director) gave notice of a planned sale of 38,730 shares worth about $251KForm 144, approximate sale date Sep 15, 2026
- Sep 15, 2026 Planned sale MOHAJER KEYVAN (Officer, Director, 10% Stockholder) gave notice of a planned sale of 137,290 shares worth about $888KForm 144, approximate sale date Sep 15, 2026
- Sep 4, 2026 Officer CFO changeEffective upon the consummation of the Mergers, the Board of Directors of the Company appointed John Collins as Chief Financial Officer of the Company.
- Sep 4, 2026 8-K Other events8-K item 8.01
- Sep 2, 2026 8-K Unregistered share sale8-K item 3.02
- Aug 27, 2026 Planned sale DIANA SROKA (Director) gave notice of a planned sale of 1,343 shares worth about $9KForm 144, approximate sale date Aug 27, 2026, under a 10b5-1 plan adopted May 28, 2026
- Aug 10, 2026 Planned sale •Majid Emami (Chief Science Officer and Senior Vice President) adopted a 10b5-1 trading planreported in the 10-Q, up to 354,048 shares, runs to Dec 31, 2026
- Aug 10, 2026 Planned sale •Michael Zagorsek (Chief Operating Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 179,888 shares, runs to Dec 31, 2026
- Aug 10, 2026 Planned sale •Eric Ball (Director) adopted a 10b5-1 trading planreported in the 10-Q, up to 150,000 shares, runs to Dec 31, 2027
- Aug 10, 2026 Planned sale •Dr. Keyvan Mohajer (Chief Executive Officer and Director) adopted a 10b5-1 trading planreported in the 10-Q, up to 1,065,848 shares, runs to Nov 30, 2026
- Aug 10, 2026 Planned sale •James M. Hom (Interim Chief Financial Officer, Chief Product Officer and Director) adopted a 10b5-1 trading planreported in the 10-Q, up to 322,804 shares, runs to Dec 31, 2026
- Aug 10, 2026 10-Q Quarterly report (10-Q)period ended Jun 30, 2026
- Aug 5, 2026 8-K Quarterly results8-K item 2.02
- Jul 24, 2026 8-K Other events8-K item 8.01
- Jul 13, 2026 8-K Current report8-K
- Jul 2, 2026 8-K Material agreement signed8-K item 1.01
- Jun 17, 2026 Planned sale MOHAJER KEYVAN (Officer, Director, 10% Stockholder) gave notice of a planned sale of 126,540 shares worth about $873KForm 144, approximate sale date Jun 18, 2026
- Jun 17, 2026 Planned sale HOM JAMES MING (Officer, Director) gave notice of a planned sale of 28,843 shares worth about $199KForm 144, approximate sale date Jun 18, 2026
- Jun 17, 2026 Planned sale EMAMI MAJID (Officer) gave notice of a planned sale of 28,843 shares worth about $199KForm 144, approximate sale date Jun 18, 2026
- Jun 17, 2026 Planned sale ZAGORSEK MICHAEL (Officer) gave notice of a planned sale of 64,994 shares worth about $448KForm 144, approximate sale date Jun 18, 2026
- May 27, 2026 8-K Bylaws or fiscal year changed, Shareholder vote results, Other events8-K items 5.03, 5.07, 8.01
- May 11, 2026 Planned sale •Majid Emami (Chief Science Officer and Senior Vice President) adopted a 10b5-1 trading planreported in the 10-Q, up to 354,048 shares, runs to Dec 31, 2026
- May 11, 2026 Planned sale •Michael Zagorsek (Chief Operating Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 179,888 shares, runs to Dec 31, 2026
- May 11, 2026 Planned sale •Eric Ball (Director) adopted a 10b5-1 trading planreported in the 10-Q, up to 150,000 shares, runs to Dec 31, 2027
- May 11, 2026 Planned sale •James M. Hom (Chief Product Officer and Director) adopted a 10b5-1 trading planreported in the 10-Q, up to 279,479 shares, runs to Sep 30, 2026
- May 11, 2026 Planned sale •Dr. Keyvan Mohajer (Chief Executive Officer and Director) adopted a 10b5-1 trading planreported in the 10-Q, up to 1,083,222 shares, runs to Aug 31, 2026
- May 11, 2026 Offering Shelf registration: shares and other securities, amount not fixedS-3ASR · We may offer and sell from time to time, in one or more series, any one of the following securities of SoundHound AI, Inc. (“SoundHound,” the “Company,” “we,” “us” or “our”): ● Class A common stock, par value $0.0001 per share (the “Class A Shares,” the “Class A Common Stock” or the “Common Stock”);
- May 11, 2026 10-Q Quarterly report (10-Q)period ended Mar 31, 2026
- May 7, 2026 8-K Quarterly results8-K item 2.02
- Apr 21, 2026 8-K Material agreement signed, Unregistered share sale, Regulation FD disclosure8-K items 1.01, 3.02, 7.01
- Mar 23, 2026 Planned sale DIANA SROKA (Director) gave notice of a planned sale of 1,343 shares worth about $9KForm 144, approximate sale date Mar 23, 2026, under a 10b5-1 plan adopted Aug 12, 2025
- Mar 20, 2026 Planned sale EMAMI MAJID (Officer) gave notice of a planned sale of 31,019 shares worth about $213KForm 144, approximate sale date Mar 20, 2026
- Mar 20, 2026 Planned sale HOM JAMES MING (Officer, Director) gave notice of a planned sale of 31,019 shares worth about $213KForm 144, approximate sale date Mar 20, 2026
- Mar 20, 2026 Planned sale MOHAJER KEYVAN (Officer, Director, 10% Stockholder) gave notice of a planned sale of 124,510 shares worth about $856KForm 144, approximate sale date Mar 20, 2026
- Mar 20, 2026 Planned sale SHARAN NITESH (Officer) gave notice of a planned sale of 44,027 shares worth about $303KForm 144, approximate sale date Mar 20, 2026
- Mar 20, 2026 Planned sale ZAGORSEK MICHAEL (Officer) gave notice of a planned sale of 52,968 shares worth about $364KForm 144, approximate sale date Mar 20, 2026
- Mar 18, 2026 Officer CFO change(the “Company”) announced that Nitesh Sharan will resign as Chief Financial Officer, effective April 3, 2026 (the “Transition Date”), to assume a leadership role at a company in the quantum computing space.
- Mar 2, 2026 Planned sale •James M. Hom (Chief Product Officer and Director) adopted a 10b5-1 trading planreported in the 10-K, up to 239,932 shares, runs to Jun 30, 2026
- Mar 2, 2026 Planned sale •Nitesh Sharan (Chief Financial Officer) adopted a 10b5-1 trading planreported in the 10-K, up to 140,754 shares, runs to Dec 31, 2026
- Mar 2, 2026 Planned sale •Dr. Keyvan Mohajer (Chief Executive Officer and Director) adopted a 10b5-1 trading planreported in the 10-K, up to 931,899 shares, runs to Jun 15, 2026
- Mar 2, 2026 10-K Annual report (10-K)period ended Dec 31, 2025
- Feb 26, 2026 8-K Quarterly results8-K item 2.02
- Dec 29, 2025 Planned sale SEYED MAJID EMAMI (Officer, 10% Stockholder) gave notice of a planned sale of 32,741 shares worth about $357KForm 144, approximate sale date Dec 26, 2025, under a 10b5-1 plan adopted Mar 11, 2025
- Dec 23, 2025 Planned sale DIANA SROKA (Director) gave notice of a planned sale of 1,343 shares worth about $15KForm 144, approximate sale date Dec 23, 2025, under a 10b5-1 plan adopted Aug 12, 2025
- Dec 22, 2025 Planned sale EMAMI MAJID (Officer) gave notice of a planned sale of 42,600 shares worth about $469KForm 144, approximate sale date Dec 22, 2025
- Dec 22, 2025 Planned sale HOM JAMES MING (Officer, Director) gave notice of a planned sale of 42,600 shares worth about $469KForm 144, approximate sale date Dec 22, 2025
- Dec 22, 2025 Planned sale MOHAJER KEYVAN (Officer, Director, 10% Stockholder) gave notice of a planned sale of 144,326 shares worth about $1.6MForm 144, approximate sale date Dec 22, 2025
- Dec 22, 2025 Planned sale SHARAN NITESH (Officer) gave notice of a planned sale of 60,780 shares worth about $670KForm 144, approximate sale date Dec 22, 2025
- Dec 22, 2025 Planned sale ZAGORSEK MICHAEL (Officer) gave notice of a planned sale of 73,406 shares worth about $809KForm 144, approximate sale date Dec 22, 2025
- Nov 17, 2025 8-K Material agreement signed (amended)8-K item 1.01
- Nov 10, 2025 Planned sale •Diana Sroka (Director) adopted a 10b5-1 trading planreported in the 10-Q, up to 5,370 shares, runs to May 31, 2026
- Nov 10, 2025 Planned sale •Dr. Keyvan Mohajer (Chief Executive Officer and Director) adopted a 10b5-1 trading planreported in the 10-Q, up to 904,045 shares, runs to Feb 28, 2026
- Nov 10, 2025 Planned sale •James M. Hom (Chief Product Officer and Director) adopted a 10b5-1 trading planreported in the 10-Q, up to 159,879 shares, runs to Mar 31, 2026
- Nov 10, 2025 Planned sale •Majid Emami (Chief Science Officer and Senior Vice President) adopted a 10b5-1 trading planreported in the 10-Q, up to 301,297 shares, runs to Mar 31, 2026
- Nov 10, 2025 10-Q Quarterly report (10-Q)period ended Sep 30, 2025
- Nov 6, 2025 8-K Quarterly results8-K item 2.02
- Sep 9, 2025 8-K Material agreement signed, Acquisition or sale of assets completed, Regulation FD disclosure, Other events8-K items 1.01, 2.01, 7.01, 8.01
- Aug 11, 2025 Planned sale •Dr. Keyvan Mohajer (Chief Executive Officer and Director) adopted a 10b5-1 trading planreported in the 10-Q, up to 728,124 shares, runs to Nov 30, 2025
- Aug 11, 2025 10-Q Quarterly report (10-Q)period ended Jun 30, 2025
- Aug 7, 2025 8-K Quarterly results8-K item 2.02
- May 30, 2025 8-K Shareholder vote results, Other events8-K items 5.07, 8.01
- May 12, 2025 Planned sale •Majid Emami (Chief Science Officer and Senior Vice President) adopted a 10b5-1 trading planreported in the 10-Q, up to 562,850 shares, runs to Dec 31, 2025
- May 12, 2025 Planned sale •Dr. Keyvan Mohajer (Chief Executive Officer and Director) adopted a 10b5-1 trading planreported in the 10-Q, up to 737,500 shares, runs to Aug 14, 2025
- May 12, 2025 Planned sale •James M. Hom (Chief Product Officer and Director) adopted a 10b5-1 trading planreported in the 10-Q, up to 69,686 shares, runs to Sep 30, 2025
- May 12, 2025 Planned sale •Michael Zagorsek (Chief Operating Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 179,888 shares, runs to Jun 30, 2026
- May 12, 2025 10-Q Quarterly report (10-Q)period ended Mar 31, 2025
- May 8, 2025 8-K Quarterly results8-K item 2.02
- Mar 11, 2025 Planned sale •Dr. Keyvan Mohajer (Chief Executive Officer and Director) adopted a 10b5-1 trading planreported in the 10-K, up to 737,500 shares, runs to Jun 15, 2025
- Mar 11, 2025 Planned sale •James M. Hom (Chief Product Officer and Director) adopted a 10b5-1 trading planreported in the 10-K, up to 29,534 shares, runs to Jun 30, 2025
- Mar 11, 2025 Planned sale •Nitesh Sharan (Chief Financial Officer) adopted a 10b5-1 trading planreported in the 10-K, up to 121,506 shares, runs to Dec 31, 2025
- Mar 11, 2025 Planned sale •Eric Ball (Director) adopted a 10b5-1 trading planreported in the 10-K, up to 150,000 shares, runs to Dec 31, 2025
- Mar 11, 2025 Planned sale •Timothy Stonehocker (Chief Technology Officer) adopted a 10b5-1 trading planreported in the 10-K, up to 395,737 shares, runs to Feb 15, 2026
- Mar 11, 2025 10-K Annual report (10-K)period ended Dec 31, 2024
- Mar 4, 2025 Late filing Late filing notice: the 10-K will be lateNT 10-K (Form 12b-25), period ended Dec 31, 2024
- Feb 27, 2025 8-K Quarterly results8-K item 2.02
- Jan 28, 2025 Offering Shelf registration: shares and other securities, amount not fixedS-3 · Shelf registered
From the SEC filing index. Insider purchases go back 180 days (the Form 4s downloaded).
Every filing
Newest first, by kind · each form links to sec.gov
| Filed | Form | What it is |
|---|---|---|
| Nov 13, 2026 | 8-K | Director or officer change |
| Nov 13, 2026 | 8-K/A | Acquisition or sale of assets completed |
| Nov 9, 2026 | 10-Q | Quarterly report |
| Nov 5, 2026 | 8-K | Quarterly results, Restructuring or exit costs |
| Sep 21, 2026 | 4 | Insider trade |
| Sep 17, 2026 | 144 | Notice of planned insider sale |
| Sep 17, 2026 | 4 | Insider trade |
| Sep 17, 2026 | 4/A | Insider trade (amended) |
| Sep 17, 2026 | 4/A | Insider trade (amended) |
| Sep 17, 2026 | 4 | Insider trade |
| Sep 17, 2026 | 4/A | Insider trade (amended) |
| Sep 17, 2026 | 4 | Insider trade |
| Sep 17, 2026 | 4/A | Insider trade (amended) |
| Sep 17, 2026 | 4 | Insider trade |
| Sep 17, 2026 | 4/A | Insider trade (amended) |
| Sep 17, 2026 | 4/A | Insider trade (amended) |
| Sep 17, 2026 | 4/A | Insider trade (amended) |
| Sep 15, 2026 | 144 | Notice of planned insider sale |
| Sep 15, 2026 | 144 | Notice of planned insider sale |
| Sep 15, 2026 | 144 | Notice of planned insider sale |
| Sep 15, 2026 | 144 | Notice of planned insider sale |
| Sep 9, 2026 | 4 | Insider trade |
| Sep 9, 2026 | 3 | New insider |
| Sep 4, 2026 | 8-K | Material agreement signed, Acquisition or sale of assets completed, Unregistered share sale, Director or officer change, Regulation FD disclosure, Other events |
| Sep 4, 2026 | 8-K | Other events |
| Sep 4, 2026 | 424B7 | |
| Sep 4, 2026 | S-8 | Shares registered for employee plans |
| Sep 4, 2026 | S-4MEF | |
| Sep 2, 2026 | 425 | |
| Sep 2, 2026 | 8-K | Unregistered share sale |
| Aug 31, 2026 | 4 | Insider trade |
| Aug 27, 2026 | 144 | Notice of planned insider sale |
| Aug 10, 2026 | 10-Q | Quarterly report |
| Aug 5, 2026 | 8-K | Quarterly results |
| Aug 3, 2026 | 4 | Insider trade |
| Aug 3, 2026 | 4 | Insider trade |
| Aug 3, 2026 | 4 | Insider trade |
| Aug 3, 2026 | 4 | Insider trade |
| Aug 3, 2026 | 4 | Insider trade |
| Aug 3, 2026 | 4 | Insider trade |
| Aug 3, 2026 | 4 | Insider trade |
| Jul 30, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Jul 24, 2026 | 425 | |
| Jul 24, 2026 | 8-K | Other events |
| Jul 13, 2026 | 8-K | Current report |
| Jul 9, 2026 | EFFECT | |
| Jul 9, 2026 | 424B3 | |
| Jul 8, 2026 | S-4/A | |
| Jul 2, 2026 | S-4/A | |
| Jul 2, 2026 | 425 | |
| Jul 2, 2026 | 8-K | Material agreement signed |
| Jun 17, 2026 | 4 | Insider trade |
| Jun 17, 2026 | 144 | Notice of planned insider sale |
| Jun 17, 2026 | 4 | Insider trade |
| Jun 17, 2026 | 4 | Insider trade |
| Jun 17, 2026 | 144 | Notice of planned insider sale |
| Jun 17, 2026 | 4 | Insider trade |
| Jun 17, 2026 | 144 | Notice of planned insider sale |
| Jun 17, 2026 | 4 | Insider trade |
| Jun 17, 2026 | 144 | Notice of planned insider sale |
| May 27, 2026 | 4 | Insider trade |
| May 27, 2026 | 4 | Insider trade |
| May 27, 2026 | 4 | Insider trade |
| May 27, 2026 | 8-K | Bylaws or fiscal year changed, Shareholder vote results, Other events |
| May 27, 2026 | S-4 | |
| May 11, 2026 | 10-Q | Quarterly report |
| May 11, 2026 | S-3ASR | Shelf registration |
| May 7, 2026 | 8-K | Quarterly results |
| Apr 30, 2026 | SCHEDULE 13G | 5%+ owner (passive) |
| Apr 29, 2026 | SCHEDULE 13G | 5%+ owner (passive) |
| Apr 21, 2026 | 425 | |
| Apr 21, 2026 | 8-K | Material agreement signed, Unregistered share sale, Regulation FD disclosure |
| Apr 9, 2026 | ARS | Annual report to shareholders |
| Apr 9, 2026 | DEF 14A | Proxy statement |
| Mar 27, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Mar 24, 2026 | 4 | Insider trade |
| Mar 24, 2026 | 4 | Insider trade |
| Mar 24, 2026 | 4 | Insider trade |
| Mar 24, 2026 | 4 | Insider trade |
| Mar 24, 2026 | 4 | Insider trade |
| Mar 24, 2026 | 4 | Insider trade |
| Mar 24, 2026 | 4 | Insider trade |
| Mar 23, 2026 | 144 | Notice of planned insider sale |
| Mar 20, 2026 | 144 | Notice of planned insider sale |
| Mar 20, 2026 | 144 | Notice of planned insider sale |
| Mar 20, 2026 | 144 | Notice of planned insider sale |
| Mar 20, 2026 | 144 | Notice of planned insider sale |
| Mar 20, 2026 | 144 | Notice of planned insider sale |
| Mar 18, 2026 | 8-K | Director or officer change |
| Mar 2, 2026 | 10-K | Annual report |
| Mar 2, 2026 | S-8 | Shares registered for employee plans |
| Feb 26, 2026 | 8-K | Quarterly results |
| Jan 13, 2026 | 4 | Insider trade |
| Dec 29, 2025 | 144 | Notice of planned insider sale |
| Dec 29, 2025 | 4 | Insider trade |
| Dec 29, 2025 | 4 | Insider trade |
| Dec 29, 2025 | 4 | Insider trade |
| Dec 29, 2025 | 4 | Insider trade |
| Dec 29, 2025 | 4 | Insider trade |
| Dec 29, 2025 | 4 | Insider trade |
Show the other 75 filings on this page
Press releases with quarterly results are attached to the 8-Ks marked "Quarterly results"; read them on Earnings releases.
Sources
SEC's filing index (data.sec.gov submissions). Each form links to the document on sec.gov.
Also
Earnings releases: the text of each quarter's results release. Statements by period: the income statement, balance sheet or cash flow of the last filings side by side.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/SOUN/export.csv") into a cell.